Purchase Order 75N92023P00380
Award Date
9/20/23
Potential Completion Date
9/19/24
Potential Value
$1M
Funding Federal Agency
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Illumina, Inc. for $902,700.00 is for the purchase of an ILLUMINA NOVASEQ 6000 SEQUENCING SYSTEM by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract was awarded on a firm fixed price basis with no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously received prime federal...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 2000 sequencers. The $202,227.89 award has a completion date of September 2, 2025 and does not utilize any set-aside designations....
This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $118,026.03 firm fixed price delivery order provides Illumina's NovaSeq 6000 sequencing reagents, Illumina DNA PCR-free sample preparation kits, and other sequencing consumables to support the agency's research and...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $197,834.87 contract provides Illumina's NextSeq 2000 and 1000/2000 sequencing reagents to support life science research and diagnostics. This award is not associated with a set-aside program. Illumina has a history...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $10,708.66 firm fixed price purchase order to Illumina, Inc. for Illumina Sample Prep Kits. The kits will be used to prepare samples to run on Illumina's NovaSeq X Plus sequencing system. This award does not have a set-aside designation and is intended to support the agency's genomic sequencing and analysis work. Illumina is a manufacturer of...
This is a federal contract award to Illumina, Inc., a manufacturer and provider of sequencing and array-based genomic analysis solutions, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH). The $110,989.24 firm fixed-price contract is for the delivery of NextSeq 1000/2000, NovaSeq X Series, and other Illumina sequencing systems and reagents to support genomic research and analysis. The award does not have a...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $249,229.80 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analytical instruments and reagents. The contract is for the provision of Illumina's sequencing systems, reagents, and associated products and services to support genomic research and diagnostics. This award...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencing systems. The $247,444.82 award does not have a set-aside designation. Illumina has been a prime contractor on prior federal awards...
The Department of Health and Human Services' National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price Delivery Order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment and reagents. The $146,891.73 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, and support services. This award...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis instruments and reagents. The $148,862.37 firm fixed price delivery order does not have a set-aside designation. Illumina has provided a range of sequencing systems, consumables, and services to support genomic research and...